Clinical Evaluation of Siddha Medicine Soosika Chooranam for Soothaga Vaayu (PCOD)

Single Centric Non Randomized Open Clinical trial Phase II in Soothaga Vaayu (PCOD) with Siddha Medicine Soosika Chooranam among patients attending OPD at Government Siddha Medical College Hospital, Chennai. - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069265

Enrollment

Registered

2024-06-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N948- Other specified conditions associated with female genital organs and menstrual cycle

Interventions

Intervention1: Soosika Chooranam: The medicine will be given 2gms twice a day for 40 days with Adjuvants(Paccharisi Kazhuneer - 1-10 days,Muthakasu kudineer -11 - 20 days, Puliyatha pasumor -21 - 30 d

Eligibility

Inclusion criteria

Inclusion criteria: a.Female aged between 15-45 years (24). b. Based upon the presence of any two of the following Rotterdam criteria 1.Oligo / Anovulation 2.Hyperandrogenism (Clinical/Biochemical) 3.Polycystic ovaries (unilateral/bilateral) c. Seeking treatment for PCOD induced infertility

Exclusion criteria

Exclusion criteria: Under any other serious systemic illness.

Design outcomes

Primary

Measure	Time frame
Regulation of menstrual cycle and harmonal profile.Timepoint: 3 months	—

Secondary

Measure	Time frame
Disappearance/reduction in the size or number of cysts.Timepoint: 3 months	—

Countries

India

Contacts

Public ContactDr U Chithra

Government Siddha Medical College,Chen

mmsankar2000@gmail.com9445716802

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026